Targeting KRAS in Cancer Therapy: Beyond Inhibitors

Saved in:
Bibliographic Details
Main Authors: Chunhui Chen, Zhiqiang Peng, Lingqiang Zhang
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:MedComm
Online Access:https://doi.org/10.1002/mco2.70267
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849714991528148992
author Chunhui Chen
Zhiqiang Peng
Lingqiang Zhang
author_facet Chunhui Chen
Zhiqiang Peng
Lingqiang Zhang
author_sort Chunhui Chen
collection DOAJ
format Article
id doaj-art-5bb7c44524be4231bc64472e6af8be8f
institution DOAJ
issn 2688-2663
language English
publishDate 2025-07-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-5bb7c44524be4231bc64472e6af8be8f2025-08-20T03:13:32ZengWileyMedComm2688-26632025-07-0167n/an/a10.1002/mco2.70267Targeting KRAS in Cancer Therapy: Beyond InhibitorsChunhui Chen0Zhiqiang Peng1Lingqiang Zhang2Department of Gastroenterology The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou ChinaState Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing) Beijing Institute of Lifeomics Beijing ChinaState Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing) Beijing Institute of Lifeomics Beijing Chinahttps://doi.org/10.1002/mco2.70267
spellingShingle Chunhui Chen
Zhiqiang Peng
Lingqiang Zhang
Targeting KRAS in Cancer Therapy: Beyond Inhibitors
MedComm
title Targeting KRAS in Cancer Therapy: Beyond Inhibitors
title_full Targeting KRAS in Cancer Therapy: Beyond Inhibitors
title_fullStr Targeting KRAS in Cancer Therapy: Beyond Inhibitors
title_full_unstemmed Targeting KRAS in Cancer Therapy: Beyond Inhibitors
title_short Targeting KRAS in Cancer Therapy: Beyond Inhibitors
title_sort targeting kras in cancer therapy beyond inhibitors
url https://doi.org/10.1002/mco2.70267
work_keys_str_mv AT chunhuichen targetingkrasincancertherapybeyondinhibitors
AT zhiqiangpeng targetingkrasincancertherapybeyondinhibitors
AT lingqiangzhang targetingkrasincancertherapybeyondinhibitors